What is Mucopolysaccharidosis? Mucopolysaccharidosis (MPS) is a group of rare inherited disorders belonging to the lysosomal storage diseases. These conditions are associated with deficiencies of specific enzymes responsible for degrading glycosaminoglycans (GAGs), also known as acid mucopolysaccharides. MPS affects multiple systems throughout the body, with primary symptoms including skeletal deformities, growth retardation, hepatosplenomegaly, cardiac problems, respiratory disorders, and neurological impairment, significantly impacting patients' quality of life and life expectancy. The estimated incidence of MPS is approximately 1 in 25,000.

What is Marfan Syndrome? Marfan Syndrome (MFS) is an autosomal dominant inherited disorder of connective tissue affecting multiple systems, including the skeletal, ocular, and cardiovascular systems. Patients typically present with disproportionately long limbs (dolichostenomelia), scoliosis, ectopia lentis, severe myopia, and most critically, aortic root dilation and dissecting aneurysms. Aortic complications are the leading cause of mortality in Marfan Syndrome patients. The incidence is approximately 1 in 5,000 individuals, with about 75% of cases having a family history and 25% arising from spontaneous mutations.

What is Paroxysmal Nocturnal Hemoglobinuria? Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired clonal disorder of hematopoietic stem cells. The classic clinical triad of PNH includes: ● Hemolytic Anemia: Characterized primarily by chronic intravascular hemolysis, often manifesting as dark, cola-colored urine (hemoglobinuria) upon waking. ● Bone Marrow Failure: Some patients present with concurrent aplastic anemia (AA) or myelodysplastic syndromes (MDS). ● Thrombosis: High incidence of venous thrombosis, potentially affecting critical sites such as hepatic, mesenteric, and cerebral veins, representing a leading cause of mortality in PNH patients. PNH patients most commonly succumb to thrombosis or progressive cytopenia. The estimated incidence is 1 to 5 cases per million individuals.

What is Fibrodysplasia Ossificans Progressiva? Fibrodysplasia Ossificans Progressiva (FOP), often referred to as "Stone Man Syndrome," is an extremely rare genetic disorder. It is characterized by congenital bilateral great toe malformations and progressive, widespread, irreversible heterotopic ossification (HO) of soft tissues throughout the body, ultimately leading to severe disability. The incidence is approximately 1 in 1 million.

What is Rett Syndrome? Rett Syndrome (RTT) is a severe neurological disorder primarily affecting females, caused by mutations in the Methyl-CpG binding protein 2 (MECP2) gene located on the X chromosome. Symptoms typically begin to manifest between 6 and 18 months of age. Following a brief period of normal development after birth, patients undergo a developmental regression, characterized by loss of acquired language and hand skills, development of stereotypic hand movements, gait abnormalities, breathing irregularities (apnea, hyperventilation), scoliosis, anxiety, and sleep disturbances. The incidence of RTT is approximately 1 in 10,000 to 1 in 15,000 live female births.